SureTrader
Home > Boards > US Listed > Cannabis >

Zynerba Pharmaceuticals (ZYNE)

ZYNE RSS Feed
Add ZYNE Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/20/2018 1:26:39 PM - Followers: 64 - Board type: Free - Posts Today: 0


Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing synthetic cannabinoid therapeutics formulated for transdermal delivery. The Company is evaluating approximately two product candidates, ZYN002 and ZYN001, in over five indications. The Company intends to study ZYN002 in patients with refractory epilepsy, osteoarthritis and Fragile X syndrome. The Company's ZYN002 is synthetic cannabidiol (CBD) formulated as a permeation-enhanced gel for transdermal delivery. ZYN002 is being developed as a clear that is designed to provide controlled drug delivery with once- or twice-daily dosing. ZYN001 is a pro-drug of tetrahydrocannabinol (THC) that enables transdermal delivery through a patch. The Company intends to test the ZYN001 patch for application to the arm, back and thigh. The Company intends to study ZYN001 in patients with fibromyalgia and peripheral neuropathic pain.

Investor Relations

Corporate Profile

Zynerba (NASDAQ: ZYNE) is pioneering the development of patent-protected, next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its two lead product candidates in development include ZYN002 and ZYN001, which are being evaluated in five indications. ZYN002 is the first and only synthetic cannabidiol (CBD) formulated as a permeation-enhanced gel for transdermal delivery. In June 2016, the company initiated the STAR 1 Phase 2 clinical trial in refractory epilepsy patients and in August 2016, initiated the STOP Phase 2 clinical trial in patients with osteoarthritis of the knee. A Phase 2 clinical trial in patients with Fragile X syndrome will be initiated in the second half of 2016. 

ZYN001, a prodrug of THC that enables transdermal delivery through the skin and circulatory system via a patch, is in preclinical development. A Phase 1 clinical trial is planned in the first half of 2017.

In August 2015, Zynerba completed an initial public offering, raising net proceeds of $42.1 million. As of June 30, 2016, cash and cash equivalents totaled $32.1 million, which is projected to fund five Phase 2 clinical trials through 2017.





Zynerba Pharmaceuticals, Inc., (Nasdaq: ZYNE) announced today the pricing of its initial public offering of 3 million shares of common stock at a public offering price of $14.00 per share, before underwriting discounts. All of the shares in the offering are being sold by Zynerba. In addition, Zynerba has granted the underwriters an option to purchase up to 450,000 additional shares of common stock at the public offering price, less the underwriting discount. Zynerba's common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading under the symbol "ZYNE" on August 5, 2015.

Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering, and Canaccord Genuity Inc. and Oppenheimer & Co. Inc. are acting as co-managers for the offering. This offering is being made only by means of a prospectus.



Extremely low float:

Fundamentals

A table providing the fundamentals of the stock
EPS (TTM) 9/30/2016 | -2.47
P/E Ratio 9/30/2016 | --
Market Cap Micro Cap | 146M
Shares Outstanding 9.95M
Float 7.2M

 

SureTrader
ZYNE
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
ZYNE News: Amended Statement of Ownership (sc 13g/a) 02/14/2018 04:57:38 PM
ZYNE News: Amended Statement of Ownership (sc 13g/a) 02/14/2018 02:56:28 PM
ZYNE News: Amended Statement of Ownership (sc 13g/a) 02/13/2018 03:52:26 PM
ZYNE News: Amended Statement of Ownership (sc 13g/a) 02/12/2018 09:10:20 AM
ZYNE News: Amended Statement of Ownership (sc 13g/a) 02/09/2018 01:17:29 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1048   Why? Technicals? I don’t see any catalysts until surfgreen 02/20/18 01:26:38 PM
#1047   Looking for a big bounce here. MD-420 02/14/18 07:59:02 AM
#1046   Not looking good today. Triminator88 02/02/18 10:34:27 AM
#1045   Woot woot!! That’s 5 higher then the highest surfgreen 01/29/18 03:59:19 PM
#1044   ANALYST ACTIONS: LADENBURG THALMANN INITIATES ZYNERBA PHARMACEUTICALS WITH a surfer 01/29/18 03:13:13 PM
#1042   Well, just put in my last sell order WolfOfGrnStreet 01/26/18 11:43:37 AM
#1041   It would sure help to hear something. a surfer 01/25/18 02:44:35 PM
#1040   Unreal manipulation for a big board stock. Need surfgreen 01/25/18 10:07:36 AM
#1039   Afternoon rally. a surfer 01/24/18 10:00:04 PM
#1038   Agreed jjh573 01/24/18 12:13:12 PM
#1037   Broken POS surfgreen 01/24/18 11:08:47 AM
#1036   $ZYNE grabbed some calls here, chart still is jjh573 01/22/18 10:58:22 AM
#1035   I excited at 12.5. May get back in MD-420 01/19/18 05:37:05 AM
#1034   This is looking like solid entry point adding KingTigerII 01/17/18 09:40:17 AM
#1033   I sold. Have a 100 shares left. I’ll WolfOfGrnStreet 01/16/18 09:58:08 PM
#1032   Golden cross forming yet this turd keeps drifting surfgreen 01/16/18 01:03:55 PM
#1031   Need to bounce here to hold the uptrend. surfgreen 01/09/18 03:09:56 PM
#1030   I believe gw is doing the same. And MD-420 01/08/18 07:35:13 AM
#1029   I hear ya, I just feel synthetic is djmurdock 01/07/18 02:17:48 AM
#1028   In all fairness sometimes quitting and re-focusing is surfgreen 01/06/18 09:02:02 PM
#1027   As most know I was a huge fan djmurdock 01/05/18 01:52:26 PM
#1024   You could be right. So many companies jumping MD-420 12/28/17 08:19:18 AM
#1023   They need to make this s+** as steady WolfOfGrnStreet 12/28/17 12:36:21 AM
#1022   Have lots of XRP! Great choice! As always Bescaredxx 12/22/17 10:05:18 AM
#1021   Don’t be dumb. Invest in this and ripple WolfOfGrnStreet 12/21/17 10:58:03 PM
#1020   Think of the midget queen as a metaphor MD-420 12/21/17 10:22:55 AM
#1019   Now that i gotta see! Lmao Bescaredxx 12/21/17 09:45:44 AM
#1018   I think it will turn out to be MD-420 12/21/17 09:33:28 AM
#1017   Isnt that normally the case! Lol they want Bescaredxx 12/21/17 07:45:35 AM
#1016   This double camel toe is really playing hard MD-420 12/21/17 07:34:25 AM
#1015   LMAO! Sweet! a surfer 12/18/17 10:09:08 AM
#1014   Full double camel toe forming! News of zyn001 Bescaredxx 12/18/17 12:50:06 AM
#1013   Is that a possible cup and handle pattern MD-420 12/14/17 09:47:31 AM
#1012   Yup! GO MYDX!!!!! Tabbysan 12/08/17 12:59:23 PM
#1010   I didn't read the release, but the market cjarmstrong 12/06/17 08:14:44 PM
#1009   Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), a surfgreen 12/06/17 11:57:51 AM
#1008   Was the news not that good. Looks like MD-420 12/06/17 10:08:21 AM
#1007   I’m not into the day to day on WolfOfGrnStreet 12/05/17 07:04:22 PM
#1006   I thought the nees was good. Maybe shorts MD-420 12/04/17 08:10:24 PM
#1005   The future is coming. This stock soars imo. WolfOfGrnStreet 12/04/17 07:35:15 PM
#1004   Market does not like them Pursuing and spending money AntonChigurh 12/04/17 03:34:45 PM
#1003   WTF Seems like inside information always leaks on surfgreen 12/04/17 01:13:09 PM
#1002   Shorts are gonna be cooked. Glad I bought MD-420 12/04/17 08:44:01 AM
#1001   16's premarket a surfer 12/04/17 08:06:03 AM
#1000   Yes you did. How did you know? We should MD-420 12/04/17 06:06:11 AM
#999   Told you so Bescaredxx 12/03/17 10:40:24 PM
#998   $ZYNE$- Excellent! Clinically Meaningful Median Reduction in Seizures surfgreen 12/03/17 03:22:57 PM
#997   This is in early stages don’t forget. If WolfOfGrnStreet 12/02/17 11:43:53 PM
#996   Sure as hell beats 6 bucks!! a surfer 12/01/17 08:25:10 PM
#995   Zyne. I’ll see you guys at the $50 WolfOfGrnStreet 11/30/17 09:49:06 PM
PostSubject